Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Silo Pharma, Inc. - Common Stock (NQ:SILO)

0.3700 +0.0200 (+5.71%)
Streaming Delayed Price Updated: 1:32 PM EDT, Apr 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 122,603
Open 0.3500
Bid (Size) 0.3622 (200)
Ask (Size) 0.3700 (300)
Prev. Close 0.3500
Today's Range 0.3435 - 0.3736
52wk Range 0.2210 - 1.190
Shares Outstanding 98,671,970
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Curious about the stocks that are showing activity after the closing bell on Friday? ↗
Via Chartmill
MissionIRNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Authorizes $1 Million Share Repurchase Program
Via Investor Brand Network

Performance

YTD
+10.3%
+10.3%
1 Month
+12.9%
+12.9%
3 Month
+4.5%
+4.5%
6 Month
-45.7%
-45.7%
1 Year
-63.7%
-63.7%

More News

Read More
Which stocks are moving before the opening bell on Tuesday? ↗
Via Chartmill
What's going on in today's after hours session ↗
Via Chartmill
News headline image
Silo Pharma Announces Share Buyback Program
From Silo Pharma, Inc.
Via GlobeNewswire
BioMedNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Receives Japan Patent Allowance for SPC-15 PTSD Candidate10
Via Investor Brand Network
Topics Intellectual Property
News headline image
Silo Pharma Receives Notice of Allowance in Japan for SPC-15, Expanding Global Intellectual Property Portfolio
From Silo Pharma, Inc.
Via GlobeNewswire
News headline image
Silo Pharma Executes Letter of Intent with Allucent to Support Phase 1 Clinical Development of SPC-15
From Silo Pharma, Inc.
Via GlobeNewswire
News headline image
Silo Pharma Partners with Allucent to Support Planned FDA Investigational New Drug Application for SPC-15 as a Therapeutic for PTSD
From Silo Pharma, Inc.
Via GlobeNewswire
News headline image
Silo Pharma Selects Alphaledger’s T12 Fund for Tokenized Real-World Asset Investments on Solana Blockchain
From Silo Pharma, Inc.
Via GlobeNewswire
News headline image
Silo Pharma Issues Update on Milestone Achievements in PTSD Drug Development and New Digital Assets Treasury Program
From Silo Pharma, Inc.
Via GlobeNewswire
News headline image
Silo Pharma Expands Crypto Treasury with First Strategic Bitcoin Purchase Reinforcing Company’s Commitment to Multi-Chain Growth
From Silo Pharma, Inc.
Via GlobeNewswire
News headline image
Silo Pharma Acquires ResearchCoin (RSC) Crypto Tokens in Support of Decentralized Science (DeSci)
From Silo Pharma, Inc.
Via GlobeNewswire
News headline image
Silo Pharma Announces Closing of $2.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
From Silo Pharma, Inc.
Via GlobeNewswire
News headline image
Stay updated with the stocks that are on the move in today's pre-market session. ↗
Via Chartmill
News headline image
Silo Pharma Announces $2.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
From Silo Pharma, Inc.
Via GlobeNewswire
News headline image
Silo Pharma Updates Strategic Agreement with Fireblocks to Secure Crypto Treasury Management
From Silo Pharma, Inc.
Via GlobeNewswire
News headline image
These stocks are gapping in today's session ↗
Via Chartmill
News headline image
Silo Pharma Signs Strategic Agreement with Fireblocks to Advance Crypto Treasury Strategy Acquisition and Security
From Silo Pharma, Inc.
Via GlobeNewswire
News headline image
EXCLUSIVE: Silo Pharma Partners With Fireblocks To Advance Crypto Treasury Strategy Acquisition And Security ↗
Via Benzinga
News headline image
These stocks are moving in today's pre-market session ↗
Via Chartmill
News headline image
Silo Pharma Announces Initial Investment in Ethereum and Solana under Cryptocurrency Treasury Strategy
From Silo Pharma, Inc.
Via GlobeNewswire
News headline image
3 Under-the-Radar Biotechs Under $5 That Could Soar 200% ↗
Via MarketBeat
News headline image
Silo Pharma Adds Japanese Patent to Expanding Global IP Portfolio for Licensed PTSD Drug
From Silo Pharma, Inc.
Via GlobeNewswire
News headline image
Silo Pharma Secures Australian Patent Covering Licensed PTSD Drug Candidate Expanding Global IP Portfolio
From Silo Pharma, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Silo Pharma, Inc. - Common Stock publicly traded?
Yes, Silo Pharma, Inc. - Common Stock is publicly traded.
What exchange does Silo Pharma, Inc. - Common Stock trade on?
Silo Pharma, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Silo Pharma, Inc. - Common Stock?
The ticker symbol for Silo Pharma, Inc. - Common Stock is SILO on the Nasdaq Stock Market
What is the current price of Silo Pharma, Inc. - Common Stock?
The current price of Silo Pharma, Inc. - Common Stock is 0.3700
When was Silo Pharma, Inc. - Common Stock last traded?
The last trade of Silo Pharma, Inc. - Common Stock was at 04/06/26 01:32 PM ET
What is the market capitalization of Silo Pharma, Inc. - Common Stock?
The market capitalization of Silo Pharma, Inc. - Common Stock is 36.51M
How many shares of Silo Pharma, Inc. - Common Stock are outstanding?
Silo Pharma, Inc. - Common Stock has 37M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.